The avifauna of the Teouma archaeological site on Efate in Vanuatu is described. It derives from the Lapita levels (3,000–2,800 ybp) and immediately overlying middens extending to ∼2,500 ybp. A total of 30 bird species is represented in the 1,714 identified specimens. Twelve species are new records for the island, which, added to previous records, indicates that minimally 39 land birds exclusive of passerines were in the original avifauna. Three-fourths of the 12 newly recorded species appear to have become extinct by the end of Lapita times, 2,800 ybp. The avifauna is dominated by eight species of columbids (47.5% Minimum Number Individuals [MNI]) including a large extinct tooth-billed pigeon, Didunculus placopedetes from Tonga, and a giant Ducula sp. cf. D. goliath from New Caledonia. Seabirds are rare despite the coastal location of the site. Fowl are important contributors to the Teouma avifauna, with the human-introduced Red Junglefowl Gallus gallus accounting for 15% MNI and present in all sampled layers. There are two species of megapodes (∼10% of MNI), with the extant Vanuatu Megapode Megapodius layardi most abundant and represented at all levels in the deposits. A substantially larger extinct megapode, Mwalau walterlinii, n. gen., n. sp., is present only in the Lapita midden area, where it is relatively rare. This extinct species was larger than all extant megapodes but smaller than the extinct Progura gallinacea from Australia, with proportions most similar to those of Alectura, and was a volant bird. The remaining significant faunal component is rails, with four species present, of which Porphyrio melanotus was the most abundant. Rare but notable records include an undescribed large rail; a parrot, Eclectus sp. cf. E. infectus; a hornbill, Rhyticeros sp. cf. R. plicatus; and a coucal, Centropus sp. indet., all conservatively considered likely to be conspecific with known taxa elsewhere in Melanesia.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 69 • No. 2